Morgan Stanley’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.16K Sell
187
-14,987
-99% -$380K ﹤0.01% 7203
2026
Q1
$362K Sell
15,174
-295,130
-95% -$8.02M ﹤0.01% 5631
2025
Q4
$9.07M Buy
310,304
+79,635
+35% +$2.48M ﹤0.01% 3690
2025
Q3
$7.37M Buy
230,669
+110,419
+92% +$3.49M ﹤0.01% 3820
2025
Q2
$3.94M Buy
120,250
+119,776
+25,269% +$3.62M ﹤0.01% 4251
2025
Q1
$13.4K Sell
474
-1,980
-81% -$62.2K ﹤0.01% 6715
2024
Q4
$72.4K Buy
2,454
+1,781
+265% +$53K ﹤0.01% 6177
2024
Q3
$20.2K Sell
673
-363
-35% -$10K ﹤0.01% 6504
2024
Q2
$27.2K Sell
1,036
-272
-21% -$7.41K ﹤0.01% 6362
2024
Q1
$37.3K Sell
1,308
-1,527
-54% -$43.6K ﹤0.01% 6323
2023
Q4
$86.1K Sell
2,835
-2,026
-42% -$54.4K ﹤0.01% 5999
2023
Q3
$134K Buy
4,861
+101
+2% +$3.23K ﹤0.01% 5747
2023
Q2
$166K Sell
4,760
-1,146
-19% -$39.8K ﹤0.01% 5720
2023
Q1
$208K Buy
5,906
+367
+7% +$13.2K ﹤0.01% 5693
2022
Q4
$192K Sell
5,539
-4,872
-47% -$171K ﹤0.01% 5683
2022
Q3
$353K Sell
10,411
-1,618
-13% -$60.1K ﹤0.01% 5447
2022
Q2
$416K Sell
12,029
-12,982
-52% -$482K ﹤0.01% 5510
2022
Q1
$1.09M Buy
25,011
+5,979
+31% +$259K ﹤0.01% 4934
2021
Q4
$944K Sell
19,032
-8,530
-31% -$442K ﹤0.01% 5113
2021
Q3
$1.47M Sell
27,562
-2,000
-7% -$110K ﹤0.01% 4803
2021
Q2
$1.71M Buy
29,562
+27,995
+1,787% +$1.59M ﹤0.01% 4749
2021
Q1
$90K Buy
+1,567
New +$95.9K ﹤0.01% 6077

Other funds holding HEAL

Morgan Stanley's HEAL Position: Q2 2026 in Review

Morgan Stanley reduced its Global X Funds Global X HealthTech ETF (HEAL) stake by 99% in Q2 2026, selling an estimated $380K and leaving 187 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #7203.

Morgan Stanley first reported a position in HEAL in Q1 2021 and has held it in 22 quarters since. The position peaked at $9.07M in Q4 2025. 28 funds tracked by Wall St. Rank hold HEAL as of Q2 2026.

  • Morgan Stanley held 187 shares of Global X Funds Global X HealthTech ETF worth $5.16K as of Q2 2026.
  • Morgan Stanley sold 14,987 Global X Funds Global X HealthTech ETF shares in Q2 2026, an estimated $380K.
  • Global X Funds Global X HealthTech ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7203 holding.
  • Morgan Stanley first reported a position in Global X Funds Global X HealthTech ETF in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's Global X Funds Global X HealthTech ETF position peaked at $9.07M in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.